Beone Medicines Ltd.-ADR
13F holders, Q2 2025 (June 30)1holders
1new positions
0sold out
$242.07avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Beone Medicines Ltd.-ADR in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 0 sold out. The largest holder was Old Mission Capital LLC ($21.3M).
- Company
- Beone Medicines Ltd.-ADR
- CUSIP
- G1146Y101
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $21.3M |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q2 2025: 87,896 shares bought, net +87,896 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Old Mission Capital LLC | 0.57% | New | 87,896 | $21.3M |
"% of holder's portfolio" is BEONE MEDICINES LTD-ADR's weight in each manager's 13F, not the share of Beone Medicines Ltd.-ADR the manager owns.